Retraction of: Scientific Reports https://doi.org/10.1038/s41598-021-03727-5, published online 20 December 2021
The Editors have retracted this Article.
After publication of this Article concerns were raised regarding the design of the study and the robustness of its central conclusions. Post-publication peer review has confirmed that:
-
there is insufficient justification for the grouping of the patients who belong to clinically heterogeneous cohorts with multiple different psychiatric disease presentations;
-
the study lacks objective outcome measures; and
-
there are concerns about the validity of the therapeutic intervention tested—specifically that Tenoten contains antibodies diluted beyond the point at which any active molecules are expected to be present and there is no molecular analysis to support the presence of molecules at these dilutions
The Editors therefore no longer have confidence in the conclusions presented.
Vladimir Anatolevich Parfenov, Dina Rustemovna Khasanova, Pavel Rudolfovich Kamchatnov and Alexey Borisovich Glazunov disagree with this retraction. Enver Ibragimovich Bogdanov, Tatiana Markovna Lokshtanova, Aleksandr Vitalevich Amelin, Natalya Nikolaevna Maslova, Nataliia Vyacheslavovna Pizova, Galina Nikolaevna Belskaya, Evgeny Robertovich Barantsevich, Gulsum Abdurahmanovna Duchshanova, Saltanat Ualihanovna Kamenova and Oleg Vladimirovich Kolokolov did not respond to correspondence from the Editors about this retraction.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Parfenov, V.A., Kamchatnov, P.R., Khasanova, D.R. et al. Retraction Note: The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders. Sci Rep 12, 15416 (2022). https://doi.org/10.1038/s41598-022-19938-3
Published:
DOI: https://doi.org/10.1038/s41598-022-19938-3
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.